API
< Back to all clusters
[HEALTH] · Greece, Spain · 2 sources

started · updated

Lung cancer advancements focus on early diagnosis and patient care

Recent developments in molecular biology and innovative therapies are shifting the landscape of lung cancer treatment. At the ESMO 2026 congress in Madrid, new therapeutic regimens for both non-small cell and small cell lung cancer were highlighted, showing potential to extend patient survival.

Medical experts, including Dr. Maria Kaparelou and Professor Thanos Dimopoulos from Alexandra Hospital, emphasize that early diagnosis is a critical factor for successful treatment. Because lung cancer often remains asymptomatic in its initial stages, low-dose computed tomography (Low-Dose CT) has emerged as a vital screening tool. Clinical studies suggest that regular screening can significantly reduce mortality rates among high-risk individuals, specifically those aged 50 to 80 with a significant smoking history.

To further address these challenges, FairLife L.C.C. will host its 6th Annual Conference, “Lung Cancer: From Scientific Progress to Real Care Experience,” on November 25, 2026, in Athens. The event aims to bridge the gap between scientific advancement and equitable patient care. The conference will feature discussions on molecular testing, biomarkers, and the latest therapeutic developments, while placing a special emphasis on the lived experiences of patients and caregivers to improve healthcare services.

Entities

Alexandra Hospital · ESMO · FairLife L.C.C. · Maria Kaparelou · Thanos Dimopoulos